JPH0610164B2 - Isoprenyl benzoate derivative and process for producing the same - Google Patents

Isoprenyl benzoate derivative and process for producing the same

Info

Publication number
JPH0610164B2
JPH0610164B2 JP15518785A JP15518785A JPH0610164B2 JP H0610164 B2 JPH0610164 B2 JP H0610164B2 JP 15518785 A JP15518785 A JP 15518785A JP 15518785 A JP15518785 A JP 15518785A JP H0610164 B2 JPH0610164 B2 JP H0610164B2
Authority
JP
Japan
Prior art keywords
solanesyl
reaction
general formula
hydrogen
isoprenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP15518785A
Other languages
Japanese (ja)
Other versions
JPS6216450A (en
Inventor
吉幸 田原
敏博 高橋
裕康 小山
良邦 鈴木
幸一郎 萩原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP15518785A priority Critical patent/JPH0610164B2/en
Publication of JPS6216450A publication Critical patent/JPS6216450A/en
Publication of JPH0610164B2 publication Critical patent/JPH0610164B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は一般式 (式中RおよびR′は同一または異なり、水素、低級ア
ルキル基、カルボキシル基、ニトロ基又はアミノ基を示
し、A及びBは水素又は両者一緒になって炭素−炭素間
の直接結合を示しそしてnは8又は9の整数である。但
しR及びR′が同時に水素を表わす場合を除く) で表わされるイソプレニル核置換安息香酸エステル誘導
体及びその製法に関する。
DETAILED DESCRIPTION OF THE INVENTION (Wherein R and R'are the same or different and each represents hydrogen, a lower alkyl group, a carboxyl group, a nitro group or an amino group, A and B represent hydrogen or together, a carbon-carbon direct bond, and n is an integer of 8 or 9, provided that R and R'represent hydrogen at the same time), and an isoprenyl nucleus-substituted benzoic acid ester derivative and a process for producing the same.

従来抗脂血作用を有していて動脈硬化症等の治療に用い
られている化合物にはデキストラン硫酸、β−シトステ
ロール、クロフィブレートなどが知られているが例えば
クロフィブレートは血清コレステロールの低下率は高い
けれども肝臓重量の増加作用等の副作用を有する。本発
明者等はイソプレノールの誘導体であるイソプレニルア
ミド誘導体が強い血清コレステロール低下作用を有する
ことを知り先に提案した(特開昭59-152354号)が、今
回前記一般式(I)で表わされる新規なイソプレニル核
置換安息香酸エステル誘導体が強い血清コレステロール
低下作用を示し、しかも肝臓重量増加等の副作用の少な
いことを見出し、本発明に至った。したがって、本発明
の化合物は心臓疾患及び循環系疾患の治療あるいは予防
薬として期待しうるものである。
Dextran sulfate, β-sitosterol, clofibrate, etc. are known as compounds having an antilipemic effect and used for the treatment of arteriosclerosis, etc., but for example, clofibrate lowers serum cholesterol. Although the rate is high, it has side effects such as liver weight increasing action. The present inventors have known that an isoprenylamide derivative, which is a derivative of isoprenol, has a strong serum cholesterol-lowering effect, and have previously proposed it (Japanese Patent Laid-Open No. 59-152354), but this time, it is represented by the general formula (I). The present inventors have found that the novel isoprenyl nucleus-substituted benzoic acid ester derivative has a strong serum cholesterol-lowering effect and has few side effects such as increase in liver weight, leading to the present invention. Therefore, the compound of the present invention can be expected as a therapeutic or prophylactic drug for heart diseases and cardiovascular diseases.

前記一般式(I)で表わされる本発明の化合物は一般式 (式中、A、Bおよびnは前記の意義を有する) で表わされるイソプレノール又はそのエステル形成性の
誘導体と、一般式 (式中、RおよびR′は前記の意義を有する) で表わされる核置換安息香酸又はそのエステル形成性の
誘導体とを反応させることによって容易に製造すること
ができる。
The compound of the present invention represented by the general formula (I) has the general formula (Wherein A, B and n have the above-mentioned meanings) and an isoprenol derivative or an ester-forming derivative thereof represented by the general formula (Wherein R and R ′ have the above-mentioned meanings) and can be easily produced by reacting with a nuclear-substituted benzoic acid or an ester-forming derivative thereof.

この反応はエステル合成の常法によって行なわれる。す
なわち、典型的には上記したイソプレノールと核置換安
息香酸とをエステル化条件下に不活性溶媒の存在又は不
在下に反応させ、エステルを合成するものである。この
反応は好ましくは酸触媒、例えば硫酸、リン酸などの無
機酸、又はp−トルエンスルホン酸、強酸型イオン交換
樹脂などの有機酸の存在下に行なわれる。不活性溶媒と
してはベンゼン、トルエン、n−ヘキサンなどの炭化水
素、ジクロロメタン、クロロホルム、ジクロロエタン、
トリクロロエタンなどのハロゲン化炭化水素、ジエチル
エーテル、ジイソプロピルエーテル、テトラヒドロフラ
ンのようなエーテル、アセトン、メチルエチルケトンな
どの低級脂肪族ケトン、酢酸エチル、酢酸ブチルのよう
なエステルその他アセトニトリル、N,N−ジメチルホル
ムアミドなどの一般的な有機溶媒が用いられる。反応は
常温から反応混合物の沸とう温度までの温度で行ないう
るが、使用した反応溶媒と生成した水とが共沸によって
反応系外に除去されるような反応温度と反応溶媒系の使
用が好ましい。
This reaction is carried out by a conventional method for ester synthesis. That is, typically, the above-mentioned isoprenol and nuclear-substituted benzoic acid are reacted under esterification conditions in the presence or absence of an inert solvent to synthesize an ester. This reaction is preferably carried out in the presence of an acid catalyst, for example, an inorganic acid such as sulfuric acid or phosphoric acid, or an organic acid such as p-toluenesulfonic acid or a strong acid ion exchange resin. As the inert solvent, hydrocarbons such as benzene, toluene and n-hexane, dichloromethane, chloroform, dichloroethane,
Halogenated hydrocarbons such as trichloroethane, diethyl ether, diisopropyl ether, ethers such as tetrahydrofuran, acetone, lower aliphatic ketones such as methyl ethyl ketone, ethyl acetate, esters such as butyl acetate, other acetonitrile, N, N-dimethylformamide, etc. Common organic solvents are used. The reaction can be carried out at a temperature from room temperature to the boiling temperature of the reaction mixture, but it is preferable to use a reaction temperature and a reaction solvent system in which the reaction solvent used and the produced water are removed out of the reaction system by azeotropic distillation. .

このエステル化反応はまたイソプレノールと核置換安息
香酸のエステル形成性の誘導体とを用いて行なうことが
できる。核置換安息香酸のエステル形成性の誘導体とし
ては、核置換安息香酸の酸ハロゲン化物、無水物、ある
いはエステルなどを挙げることができる。核置換安息香
酸の酸ハロゲン化物にはその酸のクロライド、ブロマイ
ド、ヨージドが挙げられ、これら核置換安息香酸ハライ
ドを反応体の一方とする場合は反応系に酸受容体として
塩基性化合物例えば炭酸化ナトリウム、炭酸カリウムな
どの無機塩基、又はトリエテルアミン、ジメチルアニリ
ン、ピリジン、ヒコリンなどの有機塩基を少量存在させ
ることが好ましい。この場合についても上記したエステ
ル化反応における反応溶媒が用いられる。またこの反応
において、イソプレノールの代りに対応するアルカリ金
属イソプレニルオキシドを使用してもよい。そして0°
〜100℃の範囲の温度、好ましくは0°〜室温の範囲の
温度で反応が行なわれる。核置換安息香酸無水物を反応
体の一方とする場合には、きわめて容易に所望のエステ
ルを得る。核置換安息香酸エステルを反応体の一方とす
る場合には、このエステルは通常低級アルキルエステル
であることが好ましい。この核置換安息香酸低級アルキ
ルエステルを使用する場合には、生成する低級アルコー
ルを除去しながら実施することが好ましく、また反応に
当ってエステル交換触媒としてナトリウムアルコキシ
ド、水酸化ナトリウム、水酸化カリウム、チタン酸エス
テルなどを用いることが好ましい。
This esterification reaction can also be carried out using isoprenol and an ester-forming derivative of a nuclear-substituted benzoic acid. Examples of the ester-forming derivative of nuclear-substituted benzoic acid include acid halides, anhydrides, and esters of nuclear-substituted benzoic acid. Examples of the acid halide of the nucleus-substituted benzoic acid include chloride, bromide and iodide of the acid.When these nucleus-substituted benzoic acid halides are used as one of the reactants, a basic compound such as carbonation is used as an acid acceptor in the reaction system. It is preferable that a small amount of an inorganic base such as sodium or potassium carbonate, or an organic base such as triethylamine, dimethylaniline, pyridine or hycholine be present. Also in this case, the reaction solvent in the esterification reaction described above is used. Also in this reaction, the corresponding alkali metal isoprenyl oxide may be used instead of isoprenol. And 0 °
The reaction is carried out at a temperature in the range of ~ 100 ° C, preferably in the range of 0 ° to room temperature. When a nucleus-substituted benzoic anhydride is used as one of the reactants, the desired ester can be obtained very easily. When a nucleus-substituted benzoic acid ester is used as one of the reactants, this ester is usually preferably a lower alkyl ester. When this nuclear-substituted benzoic acid lower alkyl ester is used, it is preferable to carry out it while removing the lower alcohol produced, and in the reaction, sodium alkoxide, sodium hydroxide, potassium hydroxide, titanium as an ester exchange catalyst is used. It is preferable to use an acid ester or the like.

このエステル化反応はまたイソプレノールの無機酸エス
テル例えばイソプレニルクロライド、イソプレニルブロ
マイド、イソプレニルヨージドのようなイソプレニルハ
ライド、またはジイソプレニルスルホンと、核置換安息
香酸塩、例えばナトリウム塩、カリウム塩あるいは銀塩
などを用いて行なうこともできる。
This esterification reaction is also carried out with an inorganic acid ester of isoprenol, for example, isoprenyl chloride, isoprenyl bromide, isoprenyl halide such as isoprenyl iodide, or diisoprenyl sulfone, and a nuclear-substituted benzoate such as sodium salt, potassium salt Alternatively, a silver salt or the like can be used.

このようにして得られるエステル化反応生成物は、反応
終了後必要によっては洗浄によって触媒を除去し、また
必要に応じ固型の副生物例えば塩が生成している場合な
どについては反応混合物を濾別し、濃縮し高真空蒸留に
付するか、反応化合物を酢酸エチル、クロロホルム、ヘ
キサンベンゼンなどの抽出溶媒によって抽出処理操作の
のち、シリカゲル、アルミナなどの吸着剤を用いるクロ
マトグラフィーの手段によって精製される。
In the esterification reaction product thus obtained, the catalyst is removed by washing if necessary after the completion of the reaction, and if necessary, a solid by-product such as a salt is produced by filtering the reaction mixture. Separately, concentrate and subject to high vacuum distillation, or after subjecting the reaction compound to an extraction treatment with an extraction solvent such as ethyl acetate, chloroform, hexanebenzene, etc., it is purified by a chromatographic means using an adsorbent such as silica gel or alumina. It

このエステル化反応で用いられる一般式 で示される核置換安息香酸の具体例には、p−ニトロ
−、m−ニトロ−、p−アミノ−、3,5−ジニトロ−、
3−アミノ−5−ニトロ−およびp−t−ブチル−で置
換された安息香酸などが挙げられる。
General formula used in this esterification reaction Specific examples of the nuclear-substituted benzoic acid represented by are: p-nitro-, m-nitro-, p-amino-, 3,5-dinitro-,
3-amino-5-nitro- and pt-butyl-substituted benzoic acid and the like can be mentioned.

またこのエステル化反応で用いられる一般式 で示されるイソプレノールの具体例としてはソラネソー
ル、デカプレノール、α−飽和デカプレノールなどが挙
げられる。
Also, the general formula used in this esterification reaction Specific examples of the isoprenol represented by are solanesol, decaprenol, α-saturated decaprenol and the like.

本発明の一般式(I)のRおよびR′のいずれか一方ま
たは両者がアミノ基である化合物は一般式(III)のRお
よびR′がニトロ基である化合物を用いて一般式(I)
の相応するニトロ基含有化合物を製造し次いで常法例え
ば水硫化ナトリウムあるいは硫化水素で還元するか又は
ラネーニッケル等の還元触媒の存在下常圧ないしは加圧
下で接触還元してニトロ基をアミノ基に還元して製造す
るか一般式(III)中のアミノ基を適当な保護基で保護し
て一般式(II)の化合物との反応後その保護基を除去して
製造することもできる。
In the compound of the present invention in which either or both of R and R'in the general formula (I) are amino groups, a compound of the general formula (I) in which R and R'are nitro groups is used.
To produce the corresponding nitro group-containing compound, which is then reduced by a conventional method such as sodium hydrosulfide or hydrogen sulfide, or catalytically reduced in the presence of a reducing catalyst such as Raney nickel under atmospheric pressure or pressure to reduce the nitro group to an amino group. Alternatively, the amino group in the general formula (III) may be protected with a suitable protecting group to remove the protecting group after the reaction with the compound of the general formula (II).

このようにして得られる本発明の化合物は、次の表に示
す通り血清コレステロールの低下作用を有する。
The compound of the present invention thus obtained has a serum cholesterol lowering action as shown in the following table.

なお前記表の血清コレステロール低下率は下記式で求め
た。
The serum cholesterol reduction rate in the above table was calculated by the following formula.

さらに、肝相対重量増加率は下記式で求めた。 Further, the rate of increase in relative liver weight was calculated by the following formula.

次に実施例をもって本発明を具体的に説明する。 Next, the present invention will be specifically described with reference to examples.

実施例1ソラネシル−p−ニトロベンゾエート ソラネソール95g、ピリジン50ml、酢酸エチル300m
l溶液にp−ニトロベンゾイルクロライド25gを少し
づつ、室温、攪拌下1時間かけて滴下した。更に室温攪
拌下に2時間反応させた。反応混合物に水を加え酢酸エ
チルで抽出し、有機層を5%塩酸水、5%炭酸水素ナト
リウム水、水、飽和食塩水で順次洗浄し、酢酸エチルを
減圧下に濃縮した。得られた残渣125gをベンゼン−ヘ
キサン混合溶媒を用いてシリカゲルカラムクロマト精製
し、オイル状のソラネシル−p−ニトロベンゾエート7
1.1gを得た。このオイルの一部10gをアセトン50m
lに溶解し、一夜冷蔵庫に放置し、析出した白色結晶を
別、乾燥し、ソラネシル−p−ニトロベンゾエートの
白色粉末結晶6.3gを得た。
Example 1 Solanesyl-p-nitrobenzoate Solanesol 95g, pyridine 50ml, ethyl acetate 300m
25 g of p-nitrobenzoyl chloride was added little by little to the solution 1 at room temperature with stirring over 1 hour. Further, the mixture was reacted at room temperature for 2 hours. Water was added to the reaction mixture and the mixture was extracted with ethyl acetate. The organic layer was washed successively with 5% aqueous hydrochloric acid, 5% aqueous sodium hydrogen carbonate solution, water and saturated brine, and the ethyl acetate was concentrated under reduced pressure. 125 g of the obtained residue was purified by silica gel column chromatography using a mixed solvent of benzene and hexane to give oily solanesyl-p-nitrobenzoate 7
1.1 g was obtained. Part of 10g of this oil is 50m of acetone
It was dissolved in 1 and left in a refrigerator overnight, and the precipitated white crystal was separated and dried to obtain 6.3 g of solanesyl-p-nitrobenzoate white powder crystal.

ソラネシル−p−ニトロベンゾエート m.p.51.0〜52.3℃ I.R.1720,1660,1530cm-1 実施例2デカプレニル−m−ニトロベンゾエート デカプレノール、m−ニトロベンゾイルクロライドを用
いて、実施例1と同様に反応させ、デカプレニル−m−
ニトロベンゾエートを得た。
Solanesyl-p-nitrobenzoate mp 51.0-52.3 ° C IR 1720,1660,1530 cm -1 Example 2 Decaprenyl-m-nitrobenzoate Decaprenol and m-nitrobenzoyl chloride were used and reacted in the same manner as in Example 1 to give decaprenyl-m-
Obtained nitrobenzoate.

デカプレニル−p−ニトロベンゾエート m.p.37.5〜38.2℃ I.R.(neat)1720,1665,1595cm-1 実施例3ソラネシル−p−アミノベンゾエート 実施例1で得られたソラネシル−p−ニトロベンゾエー
ト16.5gをエタノール:酢酸エチル(1:1)混合溶媒
300mlに溶解し、10%パラジウム−チャーコール200mg
を加え常圧水添する。約2時間で水素1313ml吸収した
(水素吸収理論量27℃、1.56)触媒を別後、減圧
下に濃縮し残渣17.8gを得た。残渣をベンゼン−ヘキサ
ン混合溶媒を用いてシリカゲルカラムクロマト精製し、
オイル状のソラネシル−p−アミノ−ベンゾエート10.8
gを得た。このオイル10.8gをアセトン50mlに溶解
し、一夜冷蔵庫中に放置し、析出結晶を別乾燥し、ソ
ラネシル−p−アミノベンゾエートの黄色粉末結晶6.2
gを得た。
Decaprenyl-p-nitrobenzoate mp37.5-38.2 ° C IR (neat) 1720,1665,1595 cm -1 Example 3 Solanesyl-p-aminobenzoate 16.5 g of solanesyl-p-nitrobenzoate obtained in Example 1 was mixed with an ethanol: ethyl acetate (1: 1) mixed solvent.
Dissolved in 300 ml, 10% palladium-charcoal 200 mg
And hydrogenate under normal pressure. After 1313 ml of hydrogen was absorbed in about 2 hours (theoretical amount of hydrogen absorption was 27 ° C, 1.56), the catalyst was separated and then concentrated under reduced pressure to obtain 17.8 g of residue. The residue is purified by silica gel column chromatography using a benzene-hexane mixed solvent,
Oily solanesyl-p-amino-benzoate 10.8
g was obtained. 10.8 g of this oil was dissolved in 50 ml of acetone and left overnight in the refrigerator, and the precipitated crystals were separately dried to give solanesyl-p-aminobenzoate yellow powder crystals 6.2
g was obtained.

ソラネシル−p−アミノベンゾエート m.p.55.2〜56.7℃ I.R.(neat)3420,3350,3210,1675, 1625,1600,1510cm-1 実施例4α−飽和デカプレニル−p−アミノベンゾエー
実施例1と同様に反応させ、α−飽和デカプレニル−p
−ニトロベンゾエートを得、次に実施例2と同様に還元
し、α−飽和デカプレニル−p−アミノベンゾエートを
得た。
Solanesyl-p-aminobenzoate mp 55.2-56.7 ° C IR (neat) 3420,3350,3210,1675, 1625,1600,1510 cm -1 Example 4 α-saturated decaprenyl-p-aminobenzoate Reaction was carried out in the same manner as in Example 1, and α-saturated decaprenyl-p
-Nitrobenzoate was obtained and then reduced as in Example 2 to give α-saturated decaprenyl-p-aminobenzoate.

α−飽和デカプレニル−p−アミノベンゾエート n25 D=1.5232 I.R.(neat)3475,3360,3220,1710, 1690,1620,1600,1510cm-1 実施例5デカプレニル−p−アミノベンゾエート 実施例1と同様にし、デカプレニル−p−ニトロベンゾ
エートを得、次に、実施例2と同様にし、デカプレニル
−p−アミノベンゾエートを得た。
α-Saturated decaprenyl-p-aminobenzoate n 25 D = 1.5232 IR (neat) 3475,3360,3220,1710, 1690,1620,1600,1510 cm -1 Example 5 Decaprenyl-p-aminobenzoate In the same manner as in Example 1, decaprenyl-p-nitrobenzoate was obtained, and then in the same manner as in Example 2, decaprenyl-p-aminobenzoate was obtained.

デカプレニル−p−アミノベンゾエート m.p.58.5〜60.3℃ I.R.(neat)3420,3350,3210,1675, 1625,1600,1510cm-1 実施例6ソラネシル−3,5−ジニトロベンゾエート ソラネソール68.4g、トリエチルアミン、酢酸エチル30
0ml混合溶液に3,4−ジニトロベンゾイルクロライド25
gを少しづつ室温攪拌下、30分用して加え、更に室温
攪拌下に6時間反応させた。一夜、室温に放置後、反応
物を水にあけ、酢酸エチルで抽出し、抽出層を5%塩
酸、5%重ソウ水、水、飽和食塩水で順次洗浄後、溶媒
を減圧下に濃縮した。得られた残渣88.6gをベンゼン−
ヘキサン混合溶媒を用いて、シリカゲルカラムクロマト
精製し、半結晶状のソラネシル−3,5−ジニトロベンゾ
エート57.7gを得た。この結晶状のものをn−ヘキサン
400mlに溶解し、室温に一夜放置し、析出結晶を別乾
燥すると、黄色粉末結晶のソラネシル−3,5−ジニトロ
ベンゾエート47.8gを得た。
Decaprenyl-p-aminobenzoate mp 58.5-60.3 ° C IR (neat) 3420,3350,3210,1675, 1625,1600,1510 cm -1 Example 6 Solanesyl-3,5-dinitrobenzoate Solanesol 68.4g, triethylamine, ethyl acetate 30
25 ml of 3,4-dinitrobenzoyl chloride was added to 0 ml mixed solution.
g was added little by little under stirring at room temperature for 30 minutes, and further reacted for 6 hours under stirring at room temperature. After allowing to stand at room temperature overnight, the reaction product was poured into water and extracted with ethyl acetate. The extract layer was washed successively with 5% hydrochloric acid, 5% sodium bicarbonate water, water and saturated saline, and then the solvent was concentrated under reduced pressure. . 88.6 g of the obtained residue was added to benzene-
Purification by silica gel column chromatography using a hexane mixed solvent gave 57.7 g of semi-crystalline solanesyl-3,5-dinitrobenzoate. This crystalline product is n-hexane
The crystals were dissolved in 400 ml, left at room temperature overnight, and the precipitated crystals were separately dried to obtain 47.8 g of solanesyl-3,5-dinitrobenzoate as yellow powder crystals.

ソラネシル−3,5−ジニトロベンゾエート m.p.60.7〜62.3℃ I.R.(neat)1720,1630,1540cm-1 実施例7ソラネシル−3−アミノ−5−ニトロベンゾエ
ート 実施例6で得られたソラネシル−3,5−ジニトロベンゾ
エート39.1gをメタノール250ml、トルエン150ml
に溶解し、室温攪拌下に、水硫化ナトリウム(70%Na
SH・xH2O)20gを加え、室温で2時間攪拌した。溶媒
を減圧下に濃縮し、残渣をn−ヘキサン300mlに溶解
し、不溶物を別した。n−ヘキサンを留去後、残渣3
6.5gをベンゼンを用いてシリカゲルカラムクロマト精
製し、分解したソラネソール10.7gとオイル状のソラネ
シル−3−アミノ−5−ニトロベンゾエート10.5gを得
た。アセトン50mlに溶解し、一夜冷蔵庫に放置し、析
出結晶を別乾燥し、淡黄色粉末結晶のソラネシル−3
−アミノ−5−ニトロベンゾエート7.2gを得た。
Solanesyl-3,5-dinitrobenzoate mp 60.7-62.3 ° C IR (neat) 1720,1630,1540 cm -1 Example 7 Solanesyl-3-amino-5-nitrobenzoate 39.1 g of solanesyl-3,5-dinitrobenzoate obtained in Example 6 was added to 250 ml of methanol and 150 ml of toluene.
Dissolve in water, and stir at room temperature under stirring with sodium hydrosulfide (70% Na
20 g of SH.xH 2 O) was added, and the mixture was stirred at room temperature for 2 hours. The solvent was concentrated under reduced pressure, the residue was dissolved in 300 ml of n-hexane, and the insoluble material was separated. After distilling off n-hexane, the residue 3
6.5 g of the product was purified by silica gel column chromatography using benzene to obtain 10.7 g of decomposed solanesol and 10.5 g of oily solanesyl-3-amino-5-nitrobenzoate. It was dissolved in 50 ml of acetone and left overnight in the refrigerator, and the precipitated crystals were dried separately, solanesyl-3 as pale yellow powder crystals.
7.2 g of -amino-5-nitrobenzoate was obtained.

ソラネシル−3−アミノ−5−ニトロベンゾエート m.p.65.8〜67.0℃ I.R.(neat)3470,3380,1705,1660, 1640,1580,1530cm-1 実施例8ソラネシル−p−tert−ブチルベンゾエー
ソラネソール46.5g、トリエチルアミン27.0g、ベンゼ
ン300ml混合溶液に、p−t−ブチルベンゾイルクロラ
イド14.4gを少しづつ室温攪拌下、1時間要して滴下し
た。更に室温攪拌下に7時間反応させた。一夜室温に放
置後、反応物を水にあけベンゼンで抽出し、ベンゼン層
を5%塩酸、5%炭酸水素ナトリウム水、水、飽和食塩
水で順次洗浄後、溶媒を減圧下に濃縮乾固した。残渣6
5.5gをベンゼン−ヘキサン混合溶媒を用いてシリカゲ
ルカラムクロマト精製し、オイル状のソラネシル−p−
t−ブチルベンゾエート36.5gを得た。このオイルをア
セトン180mlに溶解し、一夜冷蔵庫に放置し、析出結晶
を濾別乾燥し、ソラネシル−p−t−ブチルベンゾエー
トを33.1g得た。
Solanesyl-3-amino-5-nitrobenzoate mp 65.8-67.0 ° C IR (neat) 3470,3380,1705,1660,1640,1580,1530 cm -1 Example 8 Solanesyl-p-tert-butylbenzoate To a mixed solution of 46.5 g of solanesol, 27.0 g of triethylamine and 300 ml of benzene, 14.4 g of pt-butylbenzoyl chloride was added dropwise little by little under stirring at room temperature for 1 hour. Further, the mixture was reacted at room temperature for 7 hours. After standing overnight at room temperature, the reaction product was poured into water and extracted with benzene. The benzene layer was washed successively with 5% hydrochloric acid, 5% aqueous sodium hydrogen carbonate solution, water and saturated brine, and the solvent was concentrated to dryness under reduced pressure. . Residue 6
5.5 g was purified by silica gel column chromatography using a mixed solvent of benzene and hexane to give oily solanesyl-p-
36.5 g of t-butyl benzoate was obtained. This oil was dissolved in 180 ml of acetone and left overnight in a refrigerator, and the precipitated crystals were separated by filtration and dried to obtain 33.1 g of solanesyl-pt-butylbenzoate.

ソラネシル−p−t−ブチルベンゾエート m.p.33.2〜33.8℃ I.R.(neat)1715,1660,1605cm-1 実施例9ソラネシル−o−カルボキシベンゾエート ソラネソール75g、トリエチルアミン15ml、クロロ
ホルム300ml混合溶媒中に室温攪拌下に、少しづつ無水
フタル酸20gを加えた。2時間攪拌後、クロロホルム
抽出、水洗、濃縮した。得られた残渣99.0gをクロロホ
ルム−酢酸エチル混合溶媒を用いてシリカゲルクロマト
精製し、オイル状のソラネシル−o−カルボキシベンゾ
エート33.5gを得た。このオイルをアセトン200mlに溶
解し、冷蔵庫中に一夜放置した。析出結晶を別乾燥
し、白色粉末結晶のソラネシル−o−カルボキシベンゾ
エート28.8gを得た。
Solanesyl-pt-butylbenzoate mp33.2-33.8 ° C IR (neat) 1715,1660,1605cm -1 Example 9 Solanesyl-o-carboxybenzoate While stirring at room temperature, 20 g of phthalic anhydride was gradually added to a mixed solvent of 75 g of solanesol, 15 ml of triethylamine and 300 ml of chloroform. After stirring for 2 hours, the mixture was extracted with chloroform, washed with water, and concentrated. 99.0 g of the obtained residue was purified by silica gel chromatography using a mixed solvent of chloroform-ethyl acetate to obtain 33.5 g of oily solanesyl-o-carboxybenzoate. This oil was dissolved in 200 ml of acetone and left in the refrigerator overnight. The precipitated crystals were separately dried to obtain 28.8 g of solanesyl-o-carboxybenzoate as white powder crystals.

ソラネシル−o−カルボキシベンゾエート m.p.59.1〜59.6℃ I.R.(neat)3200,1720,1700,1660, 1595,1575cm-1 実施例10 ソラネシル−3,5−ジアミノベンゾエート 3,5−ジアミノ安息香酸12g、テトラハイドロフラン
50ml溶液中に、無水トリフルオロ酢酸50mlを氷浴下
に滴下する。滴下後、室温で1時間攪拌、更に55℃温
浴中で30分間攪拌する。溶媒を減圧下に濃縮乾固し、
残渣を得る。
Solanesyl-o-carboxybenzoate mp 59.1-59.6 ° C IR (neat) 3200,1720,1700,1660, 1595,1575 cm -1 Example 10 Solanesyl-3,5-diaminobenzoate To a solution of 3,5-diaminobenzoic acid (12 g) and tetrahydrofuran (50 ml), trifluoroacetic anhydride (50 ml) was added dropwise under an ice bath. After the dropping, the mixture is stirred for 1 hour at room temperature and further for 30 minutes in a 55 ° C warm bath. The solvent is concentrated to dryness under reduced pressure,
A residue is obtained.

次に、ソラネソール28.6g、テトラハイドロフラン100m
l溶液を加え、更にトリエチルアミン30ml、4ジメチ
ルアミノピリジン300mgを加え、室温で1時間攪拌す
る。一夜、室温に放置し、反応駅を減圧下に濃縮する。
得られた残渣49gをベンゼン−ヘキサン混合溶媒を用
いてシリカゲルカラムクロマト精製し、オイル状のソラ
ネシル−3,5−ジトリフルオロアミノベンゾエート20.8
gを得る。
Next, solanesol 28.6g, tetrahydrofuran 100m
l solution, 30 ml of triethylamine and 300 mg of 4dimethylaminopyridine are added, and the mixture is stirred at room temperature for 1 hour. Let stand overnight at room temperature and concentrate the reaction station under reduced pressure.
49 g of the obtained residue was purified by silica gel column chromatography using a mixed solvent of benzene and hexane to give oily solanesyl-3,5-ditrifluoroaminobenzoate 20.8.
get g.

次に、このオイル状物20.8gをエタノール300mlに溶解
し、濃アンモニア水50mlを加え、攪拌三夜、室温に放
置した。反応液を水にあけイソプロピルエーテルで抽出
し、水洗、減圧下に濃縮し、残渣18.2gを得た。残渣2
0.8gをクロロホルムを用いてシリカゲルカラムクロマ
ト精製し、オイル状のソラネシル−3,5−ジアミノベ
ンゾエート18.2gを得る。これをヘキサン50mlに溶解
し、一夜冷蔵庫中に放置する。析出結晶を別乾燥し、
黄色粉末結晶のソラネシル−3,5−ジアミノベンゾエー
ト7.3gを得た。
Next, 20.8 g of this oily substance was dissolved in 300 ml of ethanol, 50 ml of concentrated aqueous ammonia was added, and the mixture was left stirring at room temperature for 3 nights. The reaction solution was poured into water, extracted with isopropyl ether, washed with water, and concentrated under reduced pressure to obtain 18.2 g of a residue. Residue 2
0.8 g of the product is purified by silica gel column chromatography using chloroform to obtain 18.2 g of oily solanesyl-3,5-diaminobenzoate. This is dissolved in 50 ml of hexane and left in the refrigerator overnight. Separately dry the precipitated crystals,
7.3 g of solanesyl-3,5-diaminobenzoate as yellow powder crystals were obtained.

ソラネシル−3,5−ジアミノベンゾエート m.p.55.3〜56.0℃ I.R.(neat)3440,3360,3210,1700 1660,1615,1595cm-1 Solanesyl-3,5-diaminobenzoate mp55.3-56.0 ° C IR (neat) 3440,3360,3210,1700 1660,1615,1595cm -1

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 // A61K 31/235 ADN 8413−4C 31/24 8413−4C 31/245 8413−4C (72)発明者 萩原 幸一郎 埼玉県川越市末広町3丁目4番地8 (56)参考文献 米国特許4199587 Bulletin of the Ch emical Society of J apan,43(7),2174−2176(1970)─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location // A61K 31/235 ADN 8413-4C 31/24 8413-4C 31/245 8413-4C (72) Inventor Koichiro Hagiwara 3-4, Suehiro-cho, Kawagoe-shi, Saitama Prefecture (56) Reference US Patent 4199587 Bulletin of the Chemical Society of Japan, 43 (7), 2174-2176 (1970)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中RおよびR′は同一または異なり、水素、低級ア
ルキル基、カルボキシル基、ニトロ基又はアミノ基を示
し、A及びBは夫々水素であるか又は両者が一緒になっ
て炭素−炭素間の直接結合を示しそしてnは8又は9の
整数である。但しR及びR′が同時に水素を表わす場合
は除く) で表わされるイソプレニル核置換安息香酸エステル誘導
体。
1. A general formula (In the formula, R and R'are the same or different and each represents hydrogen, a lower alkyl group, a carboxyl group, a nitro group or an amino group, A and B are each hydrogen or both of them are taken together and carbon-carbon A direct bond and n is an integer of 8 or 9, except when R and R'represent hydrogen at the same time).
【請求項2】一般式 (但し、式中AおよびBは夫々水素であるか又は両者が
一緒になって炭素−炭素間の直接結合を示す) で表わされるイソプレノール又はそのエステル形成性の
誘導体と一般式 (但し、式中RおよびR′は同一又は異なり、水素、低
級アルキル基、カルボキシル基、ニトロ基又はアミノ基
を示す。但し、RおよびR′が同時に水素を表わす場合
を除く) で表わされる核置換安息香酸又はそのエステル形成性の
誘導体とを反応させることを特徴とする一般式 (但し、式中R、R′、A、Bおよびnは前記意義を有
する) で表わされるイソプレニル核置換安息香酸エステル誘導
体の製法。
2. General formula (Wherein A and B are each hydrogen or both of them together represent a carbon-carbon direct bond) and an isoprenol represented by the general formula (In the formula, R and R'are the same or different and each represents hydrogen, a lower alkyl group, a carboxyl group, a nitro group or an amino group, provided that R and R'represent hydrogen at the same time) General formula characterized by reacting with a substituted benzoic acid or its ester-forming derivative (However, R, R ', A, B and n have the above-mentioned meaning in the formula) A process for producing an isoprenyl nucleus-substituted benzoic acid ester derivative.
JP15518785A 1985-07-16 1985-07-16 Isoprenyl benzoate derivative and process for producing the same Expired - Fee Related JPH0610164B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15518785A JPH0610164B2 (en) 1985-07-16 1985-07-16 Isoprenyl benzoate derivative and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15518785A JPH0610164B2 (en) 1985-07-16 1985-07-16 Isoprenyl benzoate derivative and process for producing the same

Publications (2)

Publication Number Publication Date
JPS6216450A JPS6216450A (en) 1987-01-24
JPH0610164B2 true JPH0610164B2 (en) 1994-02-09

Family

ID=15600385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15518785A Expired - Fee Related JPH0610164B2 (en) 1985-07-16 1985-07-16 Isoprenyl benzoate derivative and process for producing the same

Country Status (1)

Country Link
JP (1) JPH0610164B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380345A (en) * 1993-12-03 1995-01-10 Chevron Research And Technology Company Polyalkyl nitro and amino aromatic esters and fuel compositions containing the same
US6934018B2 (en) * 2003-09-10 2005-08-23 Shearographics, Llc Tire inspection apparatus and method
US9741109B2 (en) 2014-02-12 2017-08-22 The Yokohama Rubber Co., Ltd. Tire inner surface imaging method and device

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BulletinoftheChemicalSocietyofJapan,43(7),2174−2176(1970)
米国特許4199587

Also Published As

Publication number Publication date
JPS6216450A (en) 1987-01-24

Similar Documents

Publication Publication Date Title
JPS6122046A (en) Stilbene derivative
JP2004527577A (en) Synthesis of 4-phenylbutyric acid
JPS6122047A (en) Benzoic acid derivative
JPS6215057B2 (en)
JPH0129191B2 (en)
LU83183A1 (en) NOVEL CLASS OF ACYLATED CARNITINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC USE
JPH0610164B2 (en) Isoprenyl benzoate derivative and process for producing the same
JPS6312063B2 (en)
KR100224330B1 (en) N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl)carbonyl)amino acids
EP0547231B1 (en) Phospholipase a2 inhibitor
CA1124260A (en) PROCESS FOR THE PREPARATION OF .alpha.-[4-(4- CHLOROBENZOYLAMINOETHYL)-PHENOXY]ISOBUTYRIC ACID
EP0240338B1 (en) Butenoic acid derivatives
JPS6126556B2 (en)
JP3022008B2 (en) Composition comprising a mixture of t-butoxy carbonates of trisphenols
JP4551514B2 (en) Process for producing unsaturated hydrocarbon residue-substituted anilines
JPH069547A (en) 1-acyloxyvitamin d derivative
JPS6053039B2 (en) N-Acetyl/Iramic acid derivative and method for producing the same
JP3396097B2 (en) Method for producing 4-isopropylcyclohexanecarboxylic acid ester derivative
JPH05279305A (en) Production of 3'-amino-2'-hydroxyacetophenone
JPS6126555B2 (en)
JPS62155243A (en) Improved synthesis and purification of alpha-d-propoxyphene chloride
JPS59225143A (en) Biphenylylpropionic acid derivative and its preparation
JPH1112265A (en) Production of 7-isopropoxyisoflavone
JP2894183B2 (en) Purification method of optically active glutaric acid derivative
JPH0459792A (en) Diethylenetriaminetriacetic acid oxyalkyl ester compound and production thereof

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees